AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants

AbbVie said Tuesday it will acquire Allergan for $63 billion — the latest megamerger between two pharma giants seeking new ways to grow.

The deal, combining two firms built by past acquisitions, represents a solution to existential problems facing both companies.